RxDoctor Payments Data

Michael Curley, MD

Gastroenterology · Lebanon, NHNPI 1568014710

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,772 of the $3,772 with a category attached, or 100.0%.

$3,772in general payments, 2019–2025

Across 2 payments — averaging $1886.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$2K
  • Sanofi$2K
$227,384in research payments, 2019–2025

Across 11 payments — averaging $20,671 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$191K
  • Regeneron$33K
  • E.r. Squibb & Sons, L.L.C.$4K

What the payments were for

  • Consulting fees$3,772100%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb1$2,200
Sanofi1$1,572

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,772 in reported general payments places this provider in the 80th percentile of 91 gastroenterology providers in New Hampshire.

See all gastroenterology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$102,745
Medicare patients
603
Services billed
1,304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole67$1,300
Pantoprazole Sodium17$365

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →